India has highest number of US FDA approved manufacturing facilities outside the US and yet the Indian pharma industry faces…
India has highest number of US FDA approved manufacturing facilities outside the US and yet the Indian pharma industry faces…
Regulatory woes continue to plague the AYUSH sector in India and hamper its progress despite measures to revive the traditional…
A nine-year old nutritional bar manufacturing company, Naturell India has introduced various healthy bars to the Indian market. Vijay Uttarwar,…
Netherlands-based, ‘The Odournet Group’ started its business operations in India two years back. Odournet India recently inaugurated its laboratory in…
Following PM Modi’s vision of ‘zero defect’, ‘zero effect’, pharmaceutical companies supported the Swachh Bharat campaign. The government too is…
DGFT to go online for filing documents by June 30 this year
Schedulers Logistics India is a recent entrant in the bio pharma space. In the last three months, the company provides…
National Pharmaceutical Pricing Authority (NPPA) has allowed pharma companies to increase the prices of 509 essential medicines in tune with…
Indian clinical research organisations are witnessing a downshift and companies are learning from others
More than half of top 100 pharma companies yet to register
Designed for humid climates; to co-partner with Brazilian govt in early May
More than 150 participants from different pharma companies participated
Govt officials promote India as ‘Healthcare provider to the world’
Govt officials promote India as ‘Healthcare provider to the world’
Felicitates six industry stakeholders and institutions
Ideal Cures recently received EXCiPACT certification. Suresh Pareek, Managing Director, Ideal Cures talks to Usha Sharma about the recognition and…
Pune-based HRS Process system offers innovative and cost effective heat transfer solutions offers its solution to various sectors. Its 25…
The government plans to re-brand the Jan Aushadhi initiative by opening 1000 centres across India by this June. Will this…